Boyaval, F.; Dalebout, H.; Van Zeijl, R.; Wang, W.; Fariña-Sarasqueta, A.; Lageveen-Kammeijer, G.S.M.; Boonstra, J.J.; McDonnell, L.A.; Wuhrer, M.; Morreau, H.;
et al. High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer. Cancers 2022, 14, 1552.
https://doi.org/10.3390/cancers14061552
AMA Style
Boyaval F, Dalebout H, Van Zeijl R, Wang W, Fariña-Sarasqueta A, Lageveen-Kammeijer GSM, Boonstra JJ, McDonnell LA, Wuhrer M, Morreau H,
et al. High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer. Cancers. 2022; 14(6):1552.
https://doi.org/10.3390/cancers14061552
Chicago/Turabian Style
Boyaval, Fanny, Hans Dalebout, René Van Zeijl, Wenjun Wang, Arantza Fariña-Sarasqueta, Guinevere S. M. Lageveen-Kammeijer, Jurjen J. Boonstra, Liam A. McDonnell, Manfred Wuhrer, Hans Morreau,
and et al. 2022. "High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer" Cancers 14, no. 6: 1552.
https://doi.org/10.3390/cancers14061552
APA Style
Boyaval, F., Dalebout, H., Van Zeijl, R., Wang, W., Fariña-Sarasqueta, A., Lageveen-Kammeijer, G. S. M., Boonstra, J. J., McDonnell, L. A., Wuhrer, M., Morreau, H., & Heijs, B.
(2022). High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer. Cancers, 14(6), 1552.
https://doi.org/10.3390/cancers14061552
